These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7783314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
    Oizumi K, Ohno T, Kawahara M, Kawaguchi S, Saisho M, Mitutake Y, Saito A, Tomizawa M, Koike T, Takebe K.
    Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
    Iwai N, Nakamura H, Miyazu M.
    Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
    Kuno K, Ogawa A, Hayakawa F, Miyajima Y, Takahashi H, Okumura A, Kato T, Itomi K.
    Jpn J Antibiot; 1998 Jun; 51(6):395-406. PubMed ID: 9755829
    [Abstract] [Full Text] [Related]

  • 9. Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.
    Kobayashi R, Hori D, Sano H, Suzuki D, Kishimoto K, Kobayashi K.
    J Microbiol Immunol Infect; 2018 Aug; 51(4):473-477. PubMed ID: 28690028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Fundamental and clinical studies on tazobactam/piperacillin in the pediatric field].
    Kitamura K, Nishimori H, Ihara T, Kamiya H.
    Jpn J Antibiot; 1998 Jun; 51(6):407-12. PubMed ID: 9755830
    [Abstract] [Full Text] [Related]

  • 12. [Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
    Sato T, Lochry EA, Hoberman AM, Christian MS.
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():215-32. PubMed ID: 7830288
    [Abstract] [Full Text] [Related]

  • 13. [Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    Takemoto M, Matsuo K, Oguro M, Kouchi Y.
    J Toxicol Sci; 1994 Oct; 19 Suppl 2():249-62. PubMed ID: 7830290
    [Abstract] [Full Text] [Related]

  • 14. Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
    Nishida K, Higashitani F, Hyodo A.
    Chemotherapy; 1997 Oct; 43(3):171-8. PubMed ID: 9142457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of Acute Kidney Injury Caused by Tazobactam/Piperacillin in Patients with Pneumonia and Chronic Kidney Disease: A Retrospective Observational Study.
    Morimoto T, Nagashima H, Morimoto Y, Tokuyama S.
    Yakugaku Zasshi; 2017 Oct; 137(9):1129-1136. PubMed ID: 28867699
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.